BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7622202)

  • 21. A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
    Gidlöf C; Dohlsten M; Lando P; Kalland T; Sundström C; Tötterman TH
    Blood; 1997 Mar; 89(6):2089-97. PubMed ID: 9058731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct activation of murine T cells by staphylococcal enterotoxins.
    Taub DD; Rogers TJ
    Cell Immunol; 1992 Apr; 140(2):267-81. PubMed ID: 1544163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional activity of staphylococcal enterotoxin A requires interactions with both the alpha and beta chains of HLA-DR.
    Dowd JE; Karr RW; Karp DR
    Mol Immunol; 1996 Nov; 33(16):1267-74. PubMed ID: 9129163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of isotypic and allotypic variations of MHC class II molecules on staphylococcal enterotoxin presentation to murine T cells.
    Taub DD; Newcomb JR; Rogers TJ
    Cell Immunol; 1992 May; 141(2):263-78. PubMed ID: 1315622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
    Wen R; Blackman MA; Woodland DL
    J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A.
    Abrahmsén L; Dohlsten M; Segrén S; Björk P; Jonsson E; Kalland T
    EMBO J; 1995 Jul; 14(13):2978-86. PubMed ID: 7542584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
    Pontzer CH; Russell JK; Johnson HM
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.
    Spertini F; Spits H; Geha RS
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7533-7. PubMed ID: 1881894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
    Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staphylococcal enterotoxin H contrasts closely related enterotoxins in species reactivity.
    Pettersson H; Forsberg G
    Immunology; 2002 May; 106(1):71-9. PubMed ID: 11972634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.
    Holzer U; Orlikowsky T; Zehrer C; Bethge W; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Immunology; 1997 Jan; 90(1):74-80. PubMed ID: 9038715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and mutational analysis of the histidine residues of staphylococcal enterotoxin A.
    Hoffman M; Tremaine M; Mansfield J; Betley M
    Infect Immun; 1996 Mar; 64(3):885-90. PubMed ID: 8641796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
    Moseley AB; Huston DP
    J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens.
    Labrecque N; Thibodeau J; Mourad W; Sékaly RP
    J Exp Med; 1994 Nov; 180(5):1921-9. PubMed ID: 7964467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of staphylococcal enterotoxin-driven lymphocyte proliferation by anti-MHC class II monoclonal antibody.
    Loh MT; Srinivasan N; Chan SH; Ren EC
    Hybridoma; 1995 Oct; 14(5):429-33. PubMed ID: 8575791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.
    Lando PA; Hedlund G; Dohlsten M; Kalland T
    Cancer Immunol Immunother; 1991; 33(4):231-7. PubMed ID: 2059967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.